Vitamin Shoppe Inc (NYSE:VSI) shares traded -1.64% down during most recent session to reach at the closing price of $6. The stock exchanged hands 2.66 Million shares versus average trading capacity of 610.98 Million shares, yielding a market cap of $141.66 Million. Wall Street analysts covering the stock are projecting that the stock will reach $14.67 within the next 52-weeks. The mean target projections are based on 9 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have Vitamin Shoppe Inc (NYSE:VSI) high price target of $20 and with a conservative view have low price target of $12.
Morgan Stanley “Maintained” Vitamin Shoppe Inc (NYSE:VSI) in a research note issued to investors on 8/10/17 to Equal-Weight with price target of $8.
Additionally on 8/10/17 Deutsche Bank “Maintained” Vitamin Shoppe Inc (NYSE:VSI) to Hold setting price target at $7 and on 8/10/17 Barclays “Maintained” the stock to Equal-Weight at $6. Furthermore on 5/11/17 Gabelli & Co. “Downgrades” the stock to Hold at $0.
On the other hand the company has Relative Strength Index (RSI 14) of 14.33 along with Average True Range (ATR 14) of 0.7, Consequently Vitamin Shoppe Inc (NYSE:VSI)’s weekly and monthly volatility is 8.79%, 5.58% respectively. The company’s beta value is at 0.7.
In terms of Buy, Sell or Hold recommendations, Vitamin Shoppe Inc (NYSE:VSI) has analysts’ mean recommendation of 3.1. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
According to analysts Vitamin Shoppe Inc (NYSE:VSI)’s minimum EPS for the current quarter is at $0.34 and can go high up to $0.48. The consensus mean EPS for the current quarter is at $0.39 derived from a total of 9 estimates from the analysts who have weighed in on projected earnings. However the company reported $0.55 earnings per share for the same quarter during last year.
Previously Vitamin Shoppe Inc (NYSE:VSI) reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by $-0.2. The company posted an earnings surprise of -35.1%.
While considering growth estimates of the company, it has next quarter growth estimates of -8% whereas during current quarter it has -29.1% estimations over growth, comparing to the estimations of -25.4% during current year and 5.8% for next year. Past 5 years growth of Vitamin Shoppe Inc (NYSE:VSI) observed at -4.84%, looking forward for the next 5 years it has a strong prediction of -4.35% over growth.
Vitamin Shoppe Inc (NYSE:VSI)’s revenue estimates for the current quarter are $314.74 Million according to 7 number of analysts, for the current quarter the company has high revenue estimates of $320.85 Million in contradiction of low revenue estimates of $311.1 Million. For the current year the company’s revenue estimates are $1.22 Billion compared to low analyst estimates of $1.2 Billion and high estimates of $1.25 Billion according to 10 number of analysts.
Currently Vitamin Shoppe Inc (NYSE:VSI)’s shares owned by insiders are 1.6%, whereas shares owned by institutional owners are 100%. However the six-month change in the insider ownership was recorded -21.82%, as well as three-month change in the institutional ownership was recorded -0.62%.
Vitamin Shoppe Inc (NYSE:VSI) 52-week high price stands at $28.56 and low price stands at $6.05, its price distance from 52-week high is -78.99% while its distance from 52-week low price is -0.83%. The stock hit its 52-week high on 08/16/16, and 52-week low on 08/10/17.
Vitamin Shoppe Inc (NYSE:VSI)’s trailing twelve month revenues are $1.27 Billion, whereas its price to sales ratio for the same period is 0.11. Its book value per share for the most recent quarter is $19.77 while its price to book ratio for the same period is 0.3, as for as the company’s cash per share for the most recent quarter is $0.09, however its price to cash per share ratio for the same period is 67.46. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 7.83.